ZA200704210B - Use of antioxidants for gene modulation - Google Patents

Use of antioxidants for gene modulation

Info

Publication number
ZA200704210B
ZA200704210B ZA200704210A ZA200704210A ZA200704210B ZA 200704210 B ZA200704210 B ZA 200704210B ZA 200704210 A ZA200704210 A ZA 200704210A ZA 200704210 A ZA200704210 A ZA 200704210A ZA 200704210 B ZA200704210 B ZA 200704210B
Authority
ZA
South Africa
Prior art keywords
antioxidants
gene modulation
gene
modulation
Prior art date
Application number
ZA200704210A
Other languages
English (en)
Inventor
Zicker Steven Curtis
Wedekind Karen Joy
Paetau-Robinson Inke
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of ZA200704210B publication Critical patent/ZA200704210B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
ZA200704210A 2004-11-09 2007-05-23 Use of antioxidants for gene modulation ZA200704210B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62616204P 2004-11-09 2004-11-09

Publications (1)

Publication Number Publication Date
ZA200704210B true ZA200704210B (en) 2008-09-25

Family

ID=39012035

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704210A ZA200704210B (en) 2004-11-09 2007-05-23 Use of antioxidants for gene modulation

Country Status (10)

Country Link
US (1) US11077165B2 (https=)
EP (1) EP1814394A4 (https=)
JP (1) JP2008519838A (https=)
CN (2) CN101098623B (https=)
AU (1) AU2005304546B2 (https=)
BR (1) BRPI0517563A (https=)
CA (1) CA2586936C (https=)
RU (1) RU2433819C2 (https=)
WO (1) WO2006053010A2 (https=)
ZA (1) ZA200704210B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
RU2433819C2 (ru) 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
CN101287460B (zh) 2005-08-17 2012-04-25 希尔氏宠物营养品公司 预防和治疗肾病的组合物
CN100462074C (zh) * 2007-02-14 2009-02-18 北京东方兴企食品工业技术有限公司 一种具有缓解视疲劳作用的口嚼片
EP2323638B1 (en) * 2008-07-18 2014-05-07 Hill's Pet Nutrition, Inc. Compositions and methods for treating osteoarthritis
CN102170792A (zh) * 2008-07-18 2011-08-31 希尔氏宠物营养品公司 提高老龄动物生活质量的方法
WO2010078319A1 (en) * 2008-12-30 2010-07-08 Hill's Pet Nutrition, Inc. Lipoic acid containing compositions for use in the treatment and prevention of ki dney- related disorders in companion animals
AU2009335094B2 (en) * 2008-12-30 2012-11-15 Hill's Pet Nutrition, Inc. Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
WO2011084886A1 (en) * 2010-01-06 2011-07-14 Nestec S. A. Dietary regimens useful for mimicking caloric restriction
CA2795726A1 (en) * 2010-04-06 2011-10-13 Edison Pharmaceuticals, Inc. Treatment of ataxia telangiectasia
JP2013532128A (ja) * 2010-05-12 2013-08-15 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物の炎症を抑制および予防し、炎症状態を緩和する方法
CN102884434B (zh) 2010-05-12 2015-08-19 希尔氏宠物营养品公司 用于诊断、控制和预防犬科动物炎症及减轻犬科动物炎性病况的方法
US20120282373A1 (en) * 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite and Selenium
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
JP2014018172A (ja) * 2012-07-20 2014-02-03 Kohjin Life Sciences Co Ltd 過酸化脂質生成を抑制するペットフード
CN103305579B (zh) * 2013-06-29 2014-08-27 吉林大学 一种玉米源辅助增强记忆肽及其制备方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
JPS58129954A (ja) * 1982-01-29 1983-08-03 Riboseren:Kk 新しき健康食品の製造法
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
DE4427079C2 (de) 1994-07-30 2002-12-19 Viatris Gmbh Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
US6465466B1 (en) * 1995-12-22 2002-10-15 Leif J. I. Lundblad Uses of indolo-2 [2,3b] -quinoxalines
IT1290907B1 (it) * 1997-01-31 1998-12-14 Idi Farmaceutici Spa Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
US6858399B2 (en) * 1998-06-29 2005-02-22 Robert Lamb Test for oxidative stress using cell suspensions
US20030198661A1 (en) * 2000-01-31 2003-10-23 Mars Incorporated Antioxidant compositions and methods for companion animals
GB2367489B (en) 2000-07-31 2005-02-09 Mars Inc Use of antioxidants
NZ527924A (en) 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
WO2000057876A1 (en) * 1999-03-26 2000-10-05 Lipogenics, Inc. Novel antioxidant formulations and methods for using them
US6352712B1 (en) * 1999-04-30 2002-03-05 Daniel O. Lukaczer Dietary supplements for treating fatigue-related syndromes
MXPA02002195A (es) 1999-09-09 2002-09-18 Nestle Sa Mejoramiento del estado de mascotas viejas.
US20020077349A1 (en) * 1999-11-03 2002-06-20 Hamilton Nathan D. Method of treating age-related vision impairment
US6207702B1 (en) * 1999-11-17 2001-03-27 Mars, Incorporated Method for reducing postprandial oxidative stress using cocoa procyanidins
AUPQ429399A0 (en) * 1999-11-26 1999-12-23 Heart Research Institute, The Oxidized apolipoproteins and methods of use
WO2001045661A2 (de) * 1999-12-20 2001-06-28 Cognis France, S.A. Kosmetische und/oder pharmazeutische zubereitungen
US20010043983A1 (en) * 2000-01-25 2001-11-22 Hamilton Nathan D. Nutritional supplements for aged pets
CN1423528A (zh) * 2000-04-18 2003-06-11 雀巢制品公司 营养单元
PT1317272E (pt) * 2000-05-25 2006-06-30 Boehringer Ingelheim Int Composicao para melhoramento da proteccao celular compreendendo um antioxidante lipofilo e um antioxidante hidrofilo
US20030036203A1 (en) * 2000-09-26 2003-02-20 Geoff Duke Method and graphic representation for profiling oxidative stress and cardiovascular risk
US20020115710A1 (en) 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
EA006429B1 (ru) 2001-03-09 2005-12-29 Сосьете Де Продюи Нестле С.А. Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
ES2269671T3 (es) * 2001-04-25 2007-04-01 Cobalz Limited Composiciones medicas para su uso en el tratamiento o la prevencion de una insuficiencia de vitamina b12 funcional.
US6596762B2 (en) * 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
GB0119052D0 (en) * 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
US20050244422A1 (en) * 2004-04-16 2005-11-03 Desmond Mascarenhas Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
US7247714B2 (en) * 2001-10-16 2007-07-24 Atherogenics, Inc. Protection against oxidative stress and inflammation by a cytoprotective response element
NO323683B1 (no) * 2002-03-14 2007-06-25 Pronova Biocare As Anvendelse av marine og/eller vegetabilske oljer som er behandlet med urea og/eller andre aminer eller amider i fôr til marine arter
JP4771697B2 (ja) * 2002-09-24 2011-09-14 サントリーホールディングス株式会社 認知能力の正常応答の低下予防、改善又は向上作用を有する組成物
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
CA2525560A1 (en) * 2003-05-13 2004-11-25 The Regents Of The University Of Colorado Diagnostic and therapeutic treatments related to mitochondrial disorders
DK1641351T3 (da) 2003-07-03 2014-08-25 Hills Pet Nutrition Inc Sammensætninger og fremgangsmåder til at formindske aldersrelateret forringelse af mental aktivitet hos familiedyr
MXPA06000580A (es) * 2003-07-21 2006-03-30 Unilever Nv Auxiliar de la funcion cognitiva.
US7078202B2 (en) * 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
EP2266586A1 (en) * 2004-03-23 2010-12-29 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
AU2005232392B2 (en) * 2004-04-16 2011-01-06 Société des Produits Nestlé S.A. Method and compositions for reducing oxidative stress in an animal
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US20060094734A1 (en) * 2004-11-04 2006-05-04 Newman Arnold L Composition and method for inducing alertness
RU2433819C2 (ru) 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов

Also Published As

Publication number Publication date
AU2005304546A1 (en) 2006-05-18
CN101098623A (zh) 2008-01-02
CA2586936A1 (en) 2006-05-18
US11077165B2 (en) 2021-08-03
JP2008519838A (ja) 2008-06-12
EP1814394A4 (en) 2009-08-19
EP1814394A2 (en) 2007-08-08
CN102784396A (zh) 2012-11-21
WO2006053010A2 (en) 2006-05-18
US20080069834A1 (en) 2008-03-20
AU2005304546B2 (en) 2011-07-21
RU2433819C2 (ru) 2011-11-20
RU2007121735A (ru) 2008-12-20
CN102784396B (zh) 2015-07-29
BRPI0517563A (pt) 2008-10-14
CN101098623B (zh) 2012-10-10
CA2586936C (en) 2019-08-20
WO2006053010A3 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
ZA200704210B (en) Use of antioxidants for gene modulation
IL189976A0 (en) Methods of modulating neurotrophin-mediated activity
LT2120997T (lt) Proneurotropinų veiklos moduliavimas
EP1708557A4 (en) COMPACT GROWTH MEDIUM
IL179812A0 (en) THE IMPORTANCE OF THE GENE HoxB13 FOR CANCER
IL179398A0 (en) Dpp-ib inhibitors
EP1756092A4 (en) NEW INHIBITORS OF RHO-KINASEN
GB2409953B (en) Clear channel assessment
PL1716099T3 (pl) Haloalkilokarboksamidy do zwalczania mikroorganizmów
GB0406728D0 (en) Gene therapy
EP1737926A4 (en) GROWTH ENVIRONMENT
GB0421355D0 (en) Inhibitors
IL179199A0 (en) Modulation of wrn-mediated telomere-initiated cell signaling
HUE046599T2 (hu) Elektród elrendezés folyékony fém tisztaság analizátorhoz
IL177647A0 (en) Use of enzyme
EP1727822A4 (en) NEW COMPOUNDS FOR MODULATING CELL PROLIFERATION
GB0421356D0 (en) Inhibitors
GB0410649D0 (en) Antiwear automotive formulations
GB0404535D0 (en) Antiwear automotive formulations
GB2414071B (en) Determination of antioxidant activity
GB0618641D0 (en) Frequency ramp modulation
GB0427954D0 (en) Modulator
GB0423353D0 (en) Methods of printing
GB0421068D0 (en) Methods of printing
PL114723U1 (en) Roof-timber for rectangular lining